Tramonti, C.
16  Ergebnisse:
Personensuche X
?
 
?
6

Metabolism of the EGFR tyrosin kinase inhibitor gefitinib b..:

Alfieri RR ; Galetti M ; Tramonti S...
info:eu-repo/semantics/altIdentifier/pmid/22111840.  , 2011
 
?
 
?
9

Characterization of Novel Pathogenic Variants Causing Pyrid..:

Barile, A ; Mills, P ; di Salvo, ML...
https://discovery.ucl.ac.uk/id/eprint/10138902/1/Clayton_Characterization%20of%20Novel%20Pathogenic%20Variants%20Causing%20Pyridox%28am%29ine%205%20%27-Phosphate%20Oxidase-Dependent%20Epilepsy_VoR.pdf.  , 2021
 
?
10

Pha-680626 is an effective inhibitor of the interaction bet..:

Boi D ; Souvalidou F ; Capelli D...
info:eu-repo/semantics/altIdentifier/pmid/34884931.  , 2021
 
?
11

A novel, easy assay method for human cysteine sulfinic acid..:

Tramonti A ; Contestabile R ; Florio R...
info:eu-repo/semantics/altIdentifier/pmid/34068845.  , 2021
 
?
12

Characterization of novel pathogenic variants causing pyrid..:

Barile A ; Mills P ; Di Salvo M. L...
info:eu-repo/semantics/altIdentifier/pmid/34769443.  , 2021
 
?
15

Bortezomib action in multiple myeloma: microRNA-mediated sy..:

Ballabio, E ; Armesto, M ; Breeze, C E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432485.  , 2012
 
1-15